Short communication: A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

A recombinant fusion protein of colon carcinoma binding A33 single chain antibody with cytosine deaminase displayed specific antigen binding and enzyme activity in surface plasmon resonance and is catalytic activity assay. In vitro, it selectively increased the toxicity of 5-FC to A33 antigen-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deckert, P M, Renner, C, Cohen, L S, Jungbluth, A, Ritter, G, Bertino, J R, Old, L J, Welt, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377093/
https://www.ncbi.nlm.nih.gov/pubmed/12644833
http://dx.doi.org/10.1038/sj.bjc.6600751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377093/
https://www.ncbi.nlm.nih.gov/pubmed/12644833
http://dx.doi.org/10.1038/sj.bjc.6600751

Ejemplares similares